CARMAT. France: , the designer and developer of the world's most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage heart failure, announces that the patient implanted at the Nantes University Hospital ( France) last August has been discharged from the hospital and has returned home.
The patient is doing well and left the hospital earlier this year. The CARMAT portable system will henceforth be available to all patients involved in the ongoing trial
The company has received approval from the competent authorities to include the portable power and alert system1 in the protocol of the ongoing first-in-man study, thus making it available to all patients of this trial.
The patient was discharged home after training in the management of this silent electric portable system. It is the lightest of any system currently available for powering a total artificial heart and provides patients with mobility and autonomy in excellent conditions.
Professor Alain Carpentier, co-founder of CARMAT and inventor of the Company’s self-regulated bioprosthetic artificial heart, says: “After years of suffering, a new year and a new life have started for this patient. His courage, trust and his family’s support were decisive in the success of this implantation. We express our deep appreciation to the medico-surgical teams and medical staff of the Nantes University Hospital2, whose experience and commitment have contributed to the patient’s impressive rehabilitation.”
In full agreement with the Nantes University Hospital team and CARMAT, the patient has requested that his identity remain confidential and his privacy respected, in accordance with the regulations governing this ongoing clinical trial.
Marcello Conviti, Chief Executive Officer of CARMAT, concludes: “We allocated a significant part of our teams and resources to the development of the portable device in 2014. This system is a symbol of our will to enable patients to return to as normal a life as possible. Our greatest reward has been the patient’s